Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban antithrombotic effect in stent-assisted embolization for ruptured intracranial aneurysm
ChiCTR2200067188Phase 4Not yet recruiting
- Sponsor
- Southwest Hospital of Army Medical University
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tirofiban in brain aneurysm (IA) (3 arms), sponsored by Southwest Hospital of Army Medical University. Primary endpoint: Effectiveness. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
tirofiban
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on ChiCTR2200067188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200067188.